Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial
The Journal of Heart and Lung Transplantation
- Dapagliflozin
- Pulmonary arterial hypertension
- Chronic thromboembolic pulmonary hypertension
- 6-minute walk distance
- NT-proBNP
- Humans
The paper
Ersbøll MK, Kjærgaard J, Waidtløw K et al.
The Journal of Heart and Lung Transplantation · 31 Aug 2026
